Address: Celgene s.r.o Novodvorská 994/138 14200 Praha 4,Czech Republic
Tel: +420 241 097 603
Web: http://www.celgene.eu/Czech_Republic.aspx
Celgene s.r.o. company, established in 2008, is a wholly owned subsidiary of the international headquarters of Celgene Corporation. Celgene is a biopharmaceutical company which discovers, develops and commercializes innovative therapies for the treatment of cancer and other inflammatory diseases. PharmDr. Lenka Poleková, MBA, now Country Manager, was the first employee in the Czech Republic. Her aim from the very beginning was to ensure that Celgene employs qualified professionals, who believe and act in line with the Celgene commitment to improving the lives of patients worldwide. This motto has guided our employees from the beginning of the existence of the Czech subsidiary and was reflected in the actions taken by the company, for example:
· In the very beginning, in the frame of the CUP program, we enabled treatment of 24 patients with multiple myeloma thorough a donation of the drug
· More than 300 patients have been treated as part of the clinical trials conducted by Celgene in the broad spectrum of hemato-oncological a oncological diseases (MDS, AML, CLL, MCL, DLCL, peripheral T-cell lymphoma, MM, small cell lung cancer, psoriatic arthritis, rheumatoid arthritis, prostate cancer)
· More than 1,200 hemato-oncological patients or patients with cancer have been treated so far in the Czech Republic (with Celgene products as part of clinical trials)
· As in the rest of the world, the Czech subsidiary supports in the form of grants including research and pre-clinical grants for academic institutions and independent investigators the development of the treatment of patients across the broad spectrum of hemato-oncological diseases.
Our commitment to clinical accomplishments and patient support is a guiding principle at Celgene. Some examples of the support programs for patients in Czech Republic include:
Psychological Care Program
Educational DVDs and CDs for patients
Yoga and patients
Our employees are highly trained and qualified individuals. Currently there are 12 employees working in the Czech subsidiary of Celgene who are willing to broaden their knowledge and experience and who have one joint answer to the question why they go to work – because they like their job. Our employees are in the right place, at the right time, doing the right things, to build on the Company’s scientific and commercial achievements.
Celgene is a biopharmaceutical company which discovers, develops and commercializes innovative therapies for the treatment of cancer and other inflammatory diseases.
Ms. Polekova, you established the Celgene affiliate in this country from scratch in 2008. When we spoke to Mr. Victor Ferkovich, your colleague in Russia, he commented on his own…
Martin Mátl, executive director of the Czech Association of Pharmaceutical Companies (ČAFF), shares the key priorities and challenges of the association and its members; assesses the Czech generics ecosystem, and…
CzechBio’s Serhiy Forostyak, MD, Ph.D, shares the importance of a strong platform where all actors of the biotech landscape can develop their ideas and establish valuable partnerships on a national…
Despite being recently divested from multinational pharma giant Sanofi, Czech firm Zentiva is becoming one of the fastest-growing generics manufacturing companies in Europe, with a swathe of recent international acquisitions…
The Czech Republic is aiming to carve out a space for itself among Europe’s most innovative countries by 2030 as part of the ‘Innovation Strategy of the Czech Republic 2019–2030.’…
One of the very first former-communist European states to attain a successful economic transition, the Czech Republic today puts across a compelling argument for being regarded as one of the…
Entrepreneurially-minded individuals, together with academic institutions with their fingers on the pulses of the latest trends, are propelling Czech pharma companies to great success and cementing the Czech Republic at…
Novartis Czech Republic’s Heidrun Irschik explains the potentially game-changing ramifications of Big Data on the Czech pharmaceutical and healthcare industries. The opportunities offered by big data are present and…
The general manager of ALK Czech Republic and Slovakia on his strategy which led to success within the first one and a half years of ALK’s physical presence in the…
Reckitt Benckiser’s General Manager for the CEE region, Lajos Magyari, discusses the strength of the company’s current portfolio, the importance of innovation and the success factors he focuses on to…
The general manager of Wörwag Pharma Czech Republic & Slovakia reviews to what degree the Czech and Slovak market are homogeneous and which strategies can be successfully transferred from one…
There is frequent dialogue between the pharmaceutical industry, relevant regulatory authorities, and government stakeholders in the Czech Republic, but this dialogue is often strained. However, more frequent and constructive interaction between…
Women’s health is an increasingly significant niche for pharma companies operating in the Czech Republic, with large areas of unmet need and opportunities for growth. We have great expectations…
See our Cookie Privacy Policy Here
